Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway. World J Gastroenterol 2019; 25(45): 6607-6618 [PMID: 31832001 DOI: 10.3748/wjg.v25.i45.6607]
Please LOGIN to submit a new comment.